Trial
NCT00074269
Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Breast Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of California, San Diego
Collaborators
National Cancer Institute (NCI)
Condition
Breast Cancer
Intervention
anti-thymocyte globulin
Why stopped
Terminated early due to poor enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-06-05